These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


82 related items for PubMed ID: 4414050

  • 1. L-dopa induced plasma glucagon release.
    George DT, Rayfield EJ.
    J Clin Endocrinol Metab; 1974 Sep; 39(3):618-21. PubMed ID: 4414050
    [No Abstract] [Full Text] [Related]

  • 2. L-dopa stimulation of glucagon secretion in man.
    Rayfield EJ, George DT, Eichner HL, Hsu TH.
    N Engl J Med; 1975 Sep 18; 293(12):589-91. PubMed ID: 1152893
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of adrenergic drugs on glucose and plasma glucagon and insulin responses to xylazine in sheep.
    Muggaberg J, Brockman RP.
    Res Vet Sci; 1982 Jul 18; 33(1):118-20. PubMed ID: 6753074
    [Abstract] [Full Text] [Related]

  • 5. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP, Christensen SE, Lundbaek K.
    Scand J Clin Lab Invest; 1975 May 18; 35(3):205-10. PubMed ID: 1153917
    [Abstract] [Full Text] [Related]

  • 6. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA, Cryer PE, Gerich JE.
    J Clin Invest; 1979 Jul 18; 64(1):62-71. PubMed ID: 36413
    [Abstract] [Full Text] [Related]

  • 7. [Effects of adrenergic blocking agents on HGH secretion after administration of L-Dopa].
    Ragonese F, Melluso K, Campisi R, Carducci Artenisio A.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1969-74. PubMed ID: 1231881
    [No Abstract] [Full Text] [Related]

  • 8. Immunoreactive somatostatin in the hypothalamus and other regions of the rat brain: effects of insulin, glucose, alpha- or beta-blocker and L-dopa.
    Itoh M.
    Endocrinol Jpn; 1979 Feb 30; 26(1):41-58. PubMed ID: 35344
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Propranolol enhancement of L-DOPA induced growth hormone stimulation.
    Camanni F, Massara F, Molinatti GM.
    Biomedicine; 1974 Jun 10; 21(6):241-3. PubMed ID: 4441586
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of L-dopa on plasma growth hormone, insulin, and thyroxine.
    Kansal PC, Buse J, Talbert OR, Buse MG.
    J Clin Endocrinol Metab; 1972 Jan 10; 34(1):99-105. PubMed ID: 5061778
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of intravenous infusion of L-DOPA on plasma growth hormone levels in man.
    Imura H, Nakai Y, Matsukura S, Matsuyama H.
    Horm Metab Res; 1973 Jan 10; 5(1):41-5. PubMed ID: 4706921
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.